Related Experiment Video
Updated: Dec 23, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Cerebrovascular events after transcatheter mitral valve interventions: a systematic review and meta-analysis
Gabriel Châteauneuf1, Tamim M Nazif2, Frédéric Beaupré1
1Cardiology, Quebec Heart and Lung Institute, Quebec, Quebec, Canada.
Insights
Transcatheter mitral valve interventions show low cerebrovascular event rates. Further research is needed to understand stroke mechanisms after mitral valve clip repair and transcatheter mitral valve replacement.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Neurology
Background:
- Transcatheter mitral valve interventions are increasingly used for high-risk patients with mitral valvulopathy.
- Cerebrovascular events are a potential concern following these cardiac procedures.
Purpose of the Study:
- To systematically review and meta-analyze the incidence of cerebrovascular events after transcatheter mitral valve edge-to-edge repair (MTEER) using a mitral valve clip and transcatheter mitral valve replacement (TMVR).
Main Methods:
- A systematic review and meta-analysis of studies reporting cerebrovascular events post-MTEER and TMVR.
- Primary endpoint: incidence of cerebrovascular events (periprocedural and non-periprocedural) as defined by the Mitral Valve Academic Research Consortium.
- Data pooled using a random effect model; study quality assessed with the Hawker checklist.
Main Results:
- Analysis of 60 studies (28,155 patients) for MTEER: periprocedural stroke rate 0.9%, non-periprocedural stroke rate 2.4%.
- Analysis of 26 studies (1,910 patients) for TMVR: periprocedural stroke rate 1%, non-periprocedural stroke rate 7%.
- Overall, transcatheter mitral valve interventions demonstrated low periprocedural stroke rates.
Conclusions:
- Transcatheter mitral valve interventions are associated with low rates of cerebrovascular events.
- Mechanisms underlying these cerebrovascular complications require further investigation due to limited high-quality data.
Objective:
Current guidelines support the use of transcatheter mitral valve interventions to treat some selected high-risk patients with significant mitral valvulopathy. As with any other interventional cardiac procedure, concerns have been raised about cerebrovascular event. The aim of this systematic review and meta-analysis was to determine the incidence of cerebrovascular events following (1) transcatheter mitral valve edge-to-edge repair with mitral valve clip and (2) transcatheter mitral valve replacement (TMVR).
Methods:
We conducted a systematic review of studies reporting the cerebrovascular adverse events after transcatheter mitral valve edge-to-edge repair and TMVR procedures. The primary endpoint was the incidence of cerebrovascular events as defined by the Mitral Valve Academic Research Consortium. An event that occurred within 30 days or during index hospitalisation was defined as periprocedural; otherwise it was defined as non-periprocedural. This study was designed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Aggregated study-level data were pooled using a random effect model. The quality of each study was appraised with the Hawker checklist, a method of systematically reviewing research from different paradigms.
Results:
Sixty studies totalling 28 155 patients undergoing edge-to-edge repair with mitral valve clip were included in the analysis. Periprocedural stroke and non-periprocedural stroke rates were 0.9% (95% CI 0.6 to 1.1) and 2.4% (95% CI 1.6 to 3.2), respectively. For TMVR procedures, 26 studies including 1910 patients were analysed. The estimated periprocedural stroke incidence was 1% (95% CI 0.5 to 1.8) compared with 7% (95% CI 0.8 to 18.5) for non-periprocedural stroke.
Conclusions:
Transcatheter mitral valve interventions are associated with low rates of cerebrovascular events. The exact mechanisms of these complications are still poorly understood given the relative paucity of good quality data.
Trial Registration Number:
CRD42019117257.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

